109 related articles for article (PubMed ID: 38062811)
1. Silencing of CPNE1-TRAF2 Axis Restrains the Development of Pancreatic Cancer.
Song Y; Song B; Yu Z; Li A; Xia L; Zhao Y; Lu Z; Li Z
Front Biosci (Landmark Ed); 2023 Nov; 28(11):316. PubMed ID: 38062811
[TBL] [Abstract][Full Text] [Related]
2. CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.
Liang J; Zhang J; Ruan J; Mi Y; Hu Q; Wang Z; Wei B
Med Sci Monit; 2017 Nov; 23():5504-5514. PubMed ID: 29151113
[TBL] [Abstract][Full Text] [Related]
3. CPNE1 silencing inhibits cell proliferation and accelerates apoptosis in human gastric cancer.
Li Y; Li L; Liu H; Zhou T
Eur J Pharm Sci; 2022 Oct; 177():106278. PubMed ID: 35985444
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.
Zheng M; Morgan-Lappe SE; Yang J; Bockbrader KM; Pamarthy D; Thomas D; Fesik SW; Sun Y
Cancer Res; 2008 Sep; 68(18):7570-8. PubMed ID: 18794145
[TBL] [Abstract][Full Text] [Related]
5. Exploring the role of copine 1 in human colorectal cancer: investigating its association with tumorigenesis and metastasis.
Lee JK; Lee SJ; Hah YS; Ji YH; Ju YT; Lee YJ; Jeong CY; Kim JY; Park JH; Kim JM; Cho JK; Kim HG; Kwag SJ
Ann Surg Treat Res; 2023 Dec; 105(6):385-395. PubMed ID: 38076599
[TBL] [Abstract][Full Text] [Related]
6. CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells.
Jiang Z; Jiang J; Zhao B; Yang H; Wang Y; Guo S; Deng Y; Lu D; Ma T; Wang H; Wang J
Oncol Rep; 2018 Feb; 39(2):643-650. PubMed ID: 29207139
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-489 in the proliferation and apoptosis of pancreatic carcinoma.
Zeng M; Zhou Y; Zhang Y; Wang T; Wang J
J BUON; 2019; 24(4):1574-1580. PubMed ID: 31646811
[TBL] [Abstract][Full Text] [Related]
8. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
Shao Z; Ma X; Zhang Y; Sun Y; Lv W; He K; Xia R; Wang P; Gao X
Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
[TBL] [Abstract][Full Text] [Related]
9. CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
Tang H; Zhu J; Du W; Liu S; Zeng Y; Ding Z; Zhang Y; Wang X; Liu Z; Huang J
J Exp Clin Cancer Res; 2018 Jul; 37(1):131. PubMed ID: 29970127
[TBL] [Abstract][Full Text] [Related]
10. CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway.
Wang A; Yang W; Li Y; Zhang Y; Zhou J; Zhang R; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2022 Jan; 20(1):16. PubMed ID: 35101055
[TBL] [Abstract][Full Text] [Related]
11. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
12. Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer.
Sheng B; Zhao B; Dong Y; Zhang J; Wu S; Ji H; Zhu X
Carcinogenesis; 2023 Dec; 44(10-11):748-759. PubMed ID: 37747823
[TBL] [Abstract][Full Text] [Related]
13. TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells.
Zhou DH; Yang LN; Roder C; Kalthoff H; Trauzold A
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):94-8. PubMed ID: 23392805
[TBL] [Abstract][Full Text] [Related]
14. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
[TBL] [Abstract][Full Text] [Related]
15. CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.
Trauzold A; Röder C; Sipos B; Karsten K; Arlt A; Jiang P; Martin-Subero JI; Siegmund D; Müerköster S; Pagerols-Raluy L; Siebert R; Wajant H; Kalthoff H
FASEB J; 2005 Apr; 19(6):620-2. PubMed ID: 15670977
[TBL] [Abstract][Full Text] [Related]
16. microRNA-1225 inhibit apoptosis of pancreatic cancer cells via targeting JAK1.
Zhong R; Li S; Fang K; Yang L; Wang L
Cell Cycle; 2019 May; 18(9):990-1000. PubMed ID: 30990343
[TBL] [Abstract][Full Text] [Related]
17. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
[TBL] [Abstract][Full Text] [Related]
18. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
Gao KF; Zhao YF; Liao WJ; Xu GL; Zhang JD
Kaohsiung J Med Sci; 2022 Jun; 38(6):542-553. PubMed ID: 35199935
[TBL] [Abstract][Full Text] [Related]
19. Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer.
Yang Q; Yang B; Chen M
Chin J Physiol; 2023; 66(5):388-399. PubMed ID: 37929351
[TBL] [Abstract][Full Text] [Related]
20.
Li C; Ge M; Chen D; Sun T; Jiang H; Xie Y; Lu H; Zhang B; Han L; Chen J; Zhu J
Front Oncol; 2020; 10():1730. PubMed ID: 33014855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
